DEA Archived Press Releases

Press Releases before January 20, 2025
691 Results - Showing 31 to 40
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
PRESS RELEASE

Top Source of Supply in Juvenile Fentanyl Case Charged, Thousands of Pills Found Stuffed in Microwave

DALLAS, TX - A top source of supply in the Carrollton juvenile fentanyl case – which has resulted in at least 14 juvenile overdoses, four of them fatal – has been federally charged, announced DEA Special Agent in Charge Eduardo A. Chávez. Julio Gonzalez, Jr., 18, was charged via criminal...
PRESS RELEASE

Fentanyl Distributer Tied to 13-Year-Old’s Overdose Death Pleads Guilty

DALLAS, TX - A drug distributer who was selling fentanyl-laced counterfeit M30 pills to a Carrollton middle schooler shortly before her fatal overdose pleaded guilty today to a federal drug crime, announced Eduardo A. Chávez, Special Agent in Charge of DEA Dallas Rafael Soliz, Jr., 23, was indicted in March...
PRESS RELEASE

Fentanyl Distributors Charged Following Fourth Fatal Juvenile Overdose

Dallas, TX - Two distributors who supplied the fentanyl that killed a 15-year-old girl in Carrollton last week have been federally charged, announced Eduardo A. Chávez, Special Agent in Charge of DEA Dallas. The victim, is the fourth child to die of a fentanyl overdose in the area since September...
PRESS RELEASE

Dallas Man Sentenced to 14 years in Federal Prison for Supplying Fentanyl in Rowlett Overdose

DALLAS, TX – A Dallas man has been sentenced to 14 years in federal prison for drug trafficking violations related to a 2021 overdose death, announced Special Agent in Charge Eduardo A. Chávez today. Robel Habtemariam, 20, pleaded guilty to possession with intent to manufacture and deliver fentanyl and was...
PRESS RELEASE

Denton Physician Sentenced for Over-Prescribing Opioids

DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...
PRESS RELEASE

Fentanyl Trafficker Tied to Juvenile Overdoses Pleads Guilty

DALLAS, TX - A fentanyl trafficker tied to the rash of juvenile overdoses in Carrollton and Flower Mound pleaded guilty today to a drug crime, announced DEA Dallas Special Agent in Charge Eduardo A. Chávez Magaly Mejia Cano, 29, was charged via criminal complaint in February. On Tuesday she pleaded...
PRESS RELEASE

Communities Across the Country Remove Nearly 664,000 Pounds of Unneeded Prescription Medications to Prevent Drug Misuse

WASHINGTON – On April 22, 2023, DEA and its law enforcement partners came together once again to protect our communities from prescription misuse by safely disposing of 663,725 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s bi-annual National Prescription Take...
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...